Top Markets
Coin of the day
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Rangering i aksjer #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Aksjekurs
$0.41
Sist synkronisert: 2025-01-23
Markedsverdi
$1.08M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel CohBar, Inc. (CWBR)

Kategori

Aksjeprishistorikk for CohBar, Inc. (CWBR)
Høyeste sluttskurs: $0.41 den 2025-01-01

Laveste sluttskurs: $40.85 den 2015-01-01
Aksjeprishistorikk for CohBar, Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 -20.04%
2024 -31.92%
2023 -55.78%
2022 -86.40%
2021 -68.20%
2020 -20.77%
2019 -51.89%
2018 -32.62%
2017 143.41%
2016 80.68%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE